Virtu Financial’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$403K Buy
40,356
+8,365
+26% +$83.3K 0.02% 670
2025
Q4
$317K Buy
+31,991
New +$316K 0.01% 831

Other funds holding DMII

Virtu Financial's DMII Position: Q1 2026 in Review

Virtu Financial increased its Drugs Made In America Acquisition II Corp (DMII) stake by 26% in Q1 2026, buying an estimated $83.3K and bringing the position to 40,356 shares worth $403K. The position accounts for 0.02% of the portfolio, ranked #670.

Virtu Financial first reported a position in DMII in Q4 2025 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q1 2026.

  • Virtu Financial held 40,356 shares of Drugs Made In America Acquisition II Corp worth $403K as of Q1 2026.
  • Virtu Financial bought 8,365 Drugs Made In America Acquisition II Corp shares in Q1 2026, an estimated $83.3K.
  • Drugs Made In America Acquisition II Corp made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #670 holding.
  • Virtu Financial first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.